metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Left-sided portal hypertension as a complication of chronic pancreatitis in a yo...
Journal Information
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Share
Share
Download PDF
More article options
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Open Access
Left-sided portal hypertension as a complication of chronic pancreatitis in a young patient. A case report
Visits
1480
CL Dorantes-Nava1, F Higuera-de la Tijera1, A Servín-Caamaño2, F Salas-Gordillo1, JM Abdo-Francis3, G Gutiérrez-Reyes4, MY Carmona-Castillo1, S Teutli- Carrion1, EJ Medina–Avalos1, A Servín-Higuera1, JL Pérez-Hernández1
1 Gastroenterology and Hepatology Service. General Hospital of Mexico “Dr. Eduardo Liceaga.” Mexico City, Mexico
2 Internal Medicine Service. General Hospital of Mexico “Dr. Eduardo Liceaga,” Mexico City, Mexico
3 Angeles Hospital Acoxpa. Mexico City, Mexico
4 Liver, Pancreas and Motility Laboratory (HIPAM). Department of Experimental Medicine. Faculty of Medicine. UNAM. Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 27. Issue S3

Abstracts from XVII Mexican Congress of Hepatology

More info
Introduction and Objectives

Left-sided portal hypertension occurs due to obstruction, stenosis, or thrombosis of the splenic vein. The most common causes are pancreatic, including chronic pancreatitis (31.8%-53.8%), pancreatic pseudocyst, and neoplasms.

Clinical Case

A 22-year-old man with an 11-year history of transflective pain episodes every three months, without any other symptoms. In the last six months, increased frequency and intensity. He was admitted to the emergency room for mild acute pancreatitis, amylase 181u/l, lipase 230u/l, CRP 35.7mg/L, Procalcitonin 0.04ng/ml, INR 2.4. Abdominal USG is performed with pancreatitis and intra and extrahepatic bile duct dilatation; Contrast-enhanced CT: pancreas with dilation of the main duct of 12 mm and intraductal and intraparenchymal calcifications, portal vein with a diameter of 11.8 mm with stenosis of 80% of its lumen, perigastric, periesophageal and perisplenic collateral veins, stomach with thickening of its folds (14.3 mm) and splenomegaly. He developed hematemesis and melena, panendoscopy showed a large esophageal varix which was ligated, gastric varix GOV 1. Bleeding persists, so arterography and portography were performed, which was ligated, gastric varix GOV 1. Bleeding persists, so arterography and portography were performed, which showed: splenic vein occlusion data and partial portal vein stenosis in its proximal segment. Figure 1.

Discussion

Left portal hypertension is an etiology related to pancreatic pathologies. It should be suspected if there is a history of pancreatitis coupled with de novo digestive bleeding, splenomegaly without data of cirrhosis or hematological diseases and in a patient with IGV.

Conclusion

It should always be considered regardless of the age of the patients, especially with gastrointestinal bleeding, in order to provide proper treatment.

Funding

The resources used in this study were from the hospital without any additional financing

Declaration of interest

The authors declare no potential conflicts of interest.

Full Text

Figure 1. Endoscopy A) esophageal varix B) Thickened gastric folds with areas of subepithelial hemorrhage. Contrast-enhanced CT c) Intraductal calcifications and dilation of the main duct. d) Gastric enhancement is observed after contrast administration of perigastric veins. Arteriography and portography E) proximal portal vein stenosis F) splenic vein stenosis.

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos